Have a personal or library account? Click to login
Evaluation of the tRNA-Leu (UUR) gene haplotype profile observed in canine mammary gland tumours based on comparative analysis with the MT-TL1 human gene
Brown T.P., Ganapathy V. (2020). Lactate/GPR81 signaling and proton motive force in cancer: Role in angiogenesis, immune escape, nutrition, and Warburg phenomenon. Pharmacol. Ther., 206: 107451.
Christianson T.W., Clayton D.A. (1986). In vitro transcription of human mitochondrial DNA: Accurate termination requires a region of DNA sequence that can function bidirectionally. Proc. Nat. Acad. Sci. USA, 83: 6277–6281.
Cullen J.M., Page R., Misdorp W. (2008). An overview of cancer pathogenesis, diagnosis, and management. Tum. Domest. Anim., Iowa State Press, Ames, Iowa, USA, pp. 1–44.
Grzybowska-Szatkowska L., Ślaska B. (2014). Mitochondrial NADH dehydrogenase polymorphisms are associated with breast cancer in Poland. J. Appl. Genet, 55: 173–181.
Helm M., Brulé H., Friede D., Giegé R., Pütz D., Florentz C. (2000). Search for characteristic structural features of mammalian mitochondrial tRNAs. RNA, 6: 1356–1379.
Imes D.L., Wictum E.J., Allard M.W., Sacks B.N. (2012). Identification of single nucleotide polymorphisms within the mtDNA genome of the domestic dog to discriminate individuals with common HVI haplotypes. Foren. Sci. Int. Genet., 6: 630–639.
Kim K.S., Lee S.E., Jeong H.W., Ha J.H. (1998). The complete nucleotide sequence of the domestic dog (Canis familiaris) mitochondrial genome. Mol. Phylogenet. Evol., 10: 210–220.
Kowal K., Ślaska B., Bownik A., Horecka B., Gawor J., Śmiech A., Tkaczyk A. (2019). Analysis of Mitochondrial genome from labrador (Canis lupus familiaris) with mammary gland tumour reveals novel mutations and polymorphisms. Ann. Anim. Sci., 19: 619–632.
Kowal K., Tkaczyk A., Pierzchała M., Bownik A., Ślaska B. (2020). Identification of mitochondrial DNA (NUMTs) in the nuclear genome of Daphnia magna. Int. J. Mol. Sci., 21.10.3390/ijms21228725769918433218217
Kruse B., Narasimhan N., Attardi G. (1989). Termination of transcription in human mitochondria: Identification and purification of a DNA binding protein factor that promotes termination. Cell, 58: 391–397.
Larman T.C., DePalma S.R., Hadjipanayis A.G., Protopopov A., Zhang J., Gabriel S.B., Chin L., Seidman C.E., Kucherlapati R., Seidman J.G. (2012). Spectrum of somatic mitochondrial mutations in five cancers. Proc. National Academy of Sciences of the United States of America, 109: 14087–14091.
Lorenc A., Bryk J., Golik P., Kupryjańczyk J., Ostrowski J., Pronicki M., Semczuk A., Szołkowska M., Bartnik E. (2003). Homosplasmic MELAS A3243G mtDNA mutation in a colon cancer sample. Mitochondrion, 3: 119–124.
Lott M.T., Leipzig J.N., Derbeneva O., Michael Xie H., Chalkia D., Sarmady M., Procaccio V., Wallace D.C. (2013). MtDNA variation and analysis using Mitomap and Mitomaster. Curr. Prot. Bioinf., 44.10.1002/0471250953.bi0123s44425760425489354
Martin M., Cho J., Cesare A.J., Griffith J.D., Attardi G. (2005). Termination factor-mediated DNA loop between termination and initiation sites drives mitochondrial rRNA synthesis. Cell, 123: 1227–1240.
Mayr J.A., Meierhofer D., Zimmermann F., Feichtinger R., Kögler C., Ratschek M., Schmeller N., Sperl W., Kofler B. (2008). Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma. Clin. Canc. Res., 14: 2270–2275.
Meierhofer D., Mayr J.A., Fink K., Schmeller N., Kofler B., Sperl W. (2006). Mitochondrial DNA mutations in renal cell carcinomas revealed no general impact on energy metabolism. Brit. J. Cancer, 94: 268–274.
Moraes C.T., Ciacci F., Bonilla E., Jansen C., Hirano M., Rao N., Lovelace R.E., Rowland L.P., Schon E.A., DiMauro S. (1993). Two novel pathogenic mitochondrial DNA mutations affecting organelle number and protein synthesis: Is the tRNALeu(UUR) gene an etiologic hot spot? J. Clin. Invest., 92: 2906–2915.
Okonechnikov K., Golosova O., Fursov M., Varlamov A., Vaskin Y., Efremov I., German Grehov O.G., Kandrov D., Rasputin K., Syabro M., Tleukenov T. (2012). Unipro UGENE: A unified bioinformatics toolkit. Bioinformatics, 28: 1166–1167.
Pereira L., Van Asch B., Amorim A. (2004). Standardisation of nomenclature for dog mtDNA D-loop: A prerequisite for launching a Canis familiaris database. Forensic Sci. Int., 141: 99–108.
Queen R.A., Steyn J.S., Lord P., Elson J.L. (2017). Mitochondrial DNA sequence context in the penetrance of mitochondrial t-RNA mutations: A study across multiple lineages with diagnostic implications. PLoS ONE., 12.10.1371/journal.pone.0187862569786229161289
Rahman S., Hanna M.G. (2009). Diagnosis and therapy in neuromuscular disorders: Diagnosis and new treatments in mitochondrial diseases. J. Neurol. Neurosur. Psych., 80.10.1136/jnnp.2008.15827919684231
Singh B., Modica-Napolitano J.S., Singh K.K. (2017 a). Defining the momiome: Promiscuous information transfer by mobile mitochondria and the mitochondrial genome. Semin. Cancer Biol., 47: 1–17.10.1016/j.semcancer.2017.05.004568189328502611
Singh K.K., Choudhury A.R., Tiwari H.K. (2017 c). Numtogenesis as a mechanism for development of cancer. Semin. Cancer Biol., 47: 101–109.10.1016/j.semcancer.2017.05.003568394728511886
Ślaska B., Grzybowska-Szatkowska L., Bugno-Poniewierska M., Surdyka M., Śmiech A. (2013). Nuclear and mitochondrial DNA mutation in human and canine tumors. Med. Weter., 69: 195–202.
Slaska B., Surdyka M., Brodzki A., Nisztuk S., Gurgul A., Bugno-Poniewierska M., Miech A., Roanska D., Orzelski M. (2014 a). Mitochondrial D-loop mutations can be detected in sporadic malignant tumours in dogs. Bull. Vet. Inst. Pulawy, 58: 631–637.10.2478/bvip-2014-0096
Slaska B., Grzybowska-Szatkowska L., Surdyka M., Nisztuk S., Rozanska D., Rozanski P., Smiech A., Orzelski M. (2014 b). Mitochondrial D-loop mutations and polymorphisms are connected with canine malignant cancers. Mitochond. DNA, 25: 238–243.10.3109/19401736.2013.79205423656294
Stacey S.N., Manolescu A., Sulem P., Rafnar T., Gudmundsson J., Gudjonsson S.A., Masson G., Jakobsdottir M., Thorlacius S., Helgason A., Aben K.K., Strobbe L.J., Albers-Akkers M.T., Swinkels D.W., Henderson B.E., Kolonel L.N., Le Marchand L., Millastre E., Andres R., et al. (2007). Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat. Genet., 39: 865–869.
Sun S., Wu C., Yang C., Chen J., Wang X., Nan Y., Huang Z., Ma L. (2019). Prognostic roles of mitochondrial transcription termination factors in non-small cell lung cancer. Oncol. Lett., 18: 3453–3462.
Surdyka M., Slaska B. (2017). Defect of the mitochondrial DNA hypervariable region as a risk factor for canine mammary tumour. Vet. Comp. Oncol., 15: 820–828.
Wallace K.B. (2014). Drug-induced mitochondrial neuropathy in children: A conceptual framework for critical windows of development. J. Child Neurol. SAGE Publ. Inc., 29: 1241–1248.
Wheeler J.H., Young C.K.J., Young M.J. (2019). Analysis of human mitochondrial DNA content by southern blotting and nonradioactive probe hybridization. Curr. Prot. Toxicol., 80.10.1002/cptx.75658160630982231